PHCO 737
Target-Based Drug Discovery and Cancer Treatment.
University of North Carolina at Chapel Hill · UGRD · Fall 2026
1 section
Catalog description
A lecture/discussion course that emphasizes preclinical and clinical studies for the development of anti-cancer drugs that target signal transduction. Topics include: target identification and validation, drug discovery, the process of government approval for clinical trials, design of clinical trials, and new genetic-based technologies to foster drug development.
Sections
Current meeting, instructor, credit, and enrollment details
001
Availability not recently verifiedClass #north_carolina_chapel_hill-8013Fall 2026UGRD2 credits
- Days & times
- No scheduled meeting time
- Meeting dates
- —
- Location
- —
- Instructor
- Staff
Class numbers and section codes come from the registrar.
Spot missing or incorrect course data?